Published Evidence Library
Knee OsteoarthritisRandomized Controlled Trial·2016

Knee Osteoarthritis and Pulsed Electromagnetic Field Therapy: Evidence From a Randomized Clinical Trial

Citation: Bagnato GL, Miceli G, Marino N, Sciortino D, Bagnato GF. Pulsed Electromagnetic Fields in Knee Osteoarthritis: A Double-Blind Placebo-Controlled Randomized Clinical Trial. Rheumatology (Oxford), 2016. DOI: 10.1093/rheumatology/kev426

Knee osteoarthritis affects hundreds of millions of people worldwide and remains one of the leading causes of pain and physical limitation in adults. As disease progresses, patients frequently report reduced mobility, impaired sleep, decreased exercise tolerance, and declining quality of life.

Although pharmacologic treatments can provide relief for some patients, long-term treatment strategies increasingly emphasize multimodal approaches that may include physical therapy, weight management, rehabilitation programs, injections, and non-drug interventions.

One area of ongoing investigation involves pulsed electromagnetic field (PEMF) therapy. A randomized, double-blind, placebo-controlled study by Bagnato and colleagues evaluated wearable PEMF therapy in individuals with symptomatic knee osteoarthritis. Published in Rheumatology, the study remains one of the more frequently cited investigations within this category.

Study Design

The study enrolled 60 patients with radiographic evidence of knee osteoarthritis and persistent pain levels exceeding 40 mm on a visual analog scale. Participants were randomized to active PEMF therapy or placebo treatment.

  • 12 hours daily
  • 1 month duration

Study Findings

“PEMF therapy is effective for pain management in knee OA patients and also affects pain threshold and physical functioning.” — Bagnato et al.

Pain scores are important, but functional outcomes may be equally meaningful. Questions frequently asked by patients include: can I walk farther, can I move more comfortably, can I return to activities I enjoy, can I sleep better?

“Patients rarely describe outcomes using statistical endpoints. They describe whether they can climb stairs, exercise, or participate in daily activities.”
Samir S. Awad, MD — Medical Director, Electrome

Why Knee Osteoarthritis Matters for Bioelectric Therapy

  • high prevalence
  • substantial economic burden
  • need for long-term management
  • growing interest in opioid-sparing care pathways
“Knee osteoarthritis sits at the intersection of significant patient need and increasing demand for safe, non-drug therapeutic options.”
Nev Zubcevik, DO — Co-founder, Electrome

Important Context

The study was relatively small and investigators noted that larger studies remain important. Clinical decisions should always incorporate physician guidance, patient-specific circumstances, and the broader body of evidence. However, randomized placebo-controlled investigations such as this contribute important data points supporting continued study of wearable bioelectric interventions.

“The future opportunity is connecting therapeutic signals, software systems, and outcomes data so every interaction helps improve future care.”
Erik Nilsen, PhD — CTO, Electrome
Back to Publications

Educational summary only. Not medical advice. Outcomes described here are those reported by the cited investigators in the cited publication. Individual results vary. Consult a qualified healthcare provider before making treatment decisions.